Personalized lupus drug study halted early
NCT ID NCT05306873
Summary
This study aimed to see if adding a drug called voclosporin to a standard lupus medication (mycophenolate mofetil, or MMF) could better control disease activity. It tested this in a small group of adults with active, non-organ-threatening lupus, grouping them by their immune system profiles. The trial was terminated early and did not complete its planned enrollment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia University Medical Center: Department of Medicine, Division of Rheumatology
New York, New York, 10032, United States
-
Emory University School of Medicine: Division of Rheumatology
Atlanta, Georgia, 30307, United States
-
Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases
Manhasset, New York, 11030, United States
-
Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases
Boston, Massachusetts, 02114, United States
-
Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program
Oklahoma City, Oklahoma, 73104, United States
-
PennState Health Milton S. Hershey Medical Center: Division of Rheumatology
Hershey, Pennsylvania, 17033, United States
-
Piedmont Healthcare: Rheumatology Atlanta
Atlanta, Georgia, 30318, United States
-
UCLA Medical Center: Division of Rheumatology
Los Angeles, California, 90095, United States
-
University of North Carolina at Chapel Hill; Thurston Arthritis Research Center: Division of Rheumatology, Allergy, and Immunology
Chapel Hill, North Carolina, 27599, United States
-
Yale University School of Medicine: Rheumatology, Allergy & Immunology
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.